Forepont Capital Partners

Overview

Forepont Capital Partners is a venture capital firm established in 2017 in New York [2][4] that invests in early-stage companies in healthcare and life sciences, with a focus on artificial intelligence and neuroscience [1]. The firm concentrates on AI applications advancing neuroscience, brain AI applications transforming healthcare and sectors such as safety, education and defense, and biological frameworks enhancing AI capabilities [7]. Forepont's portfolio spans implantable neural interfaces, rapid diagnostics for infectious diseases, precision medicine for transplant and chronic disease, AI applied to neurological diseases, sleep apnea management, a universal pneumococcus vaccine, active endovascular guidewires, microbiome therapeutics, biopharmaceutical manufacturing technologies and women's health [8]. The firm maintains offices in New York, Palo Alto, London, Paris and Dubai [6] and takes board positions in most of its portfolio companies while sizing investments to preserve strategic influence [9].

The company's own site places it in New York: Founded in 2017 in New York; described as 'a venture capital firm established in 2017 in New York'; listed as present in New York alongside . [2]

Forepont Capital Partners states it is a venture capital firm established in 2017 in New York. [4]

Forepont Capital LLC lists its address as 230 Park Avenue, 3rd Floor West, New York, NY 10169. [5]

Growth & traction

Forepont Capital Partners says it is located in New York, Palo Alto, London, Paris and Dubai. [6]